Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients.
Status:
Completed
Trial end date:
2019-04-20
Target enrollment:
Participant gender:
Summary
This study aimed to appraise effectiveness and tolerability of lidocaine 5% spray in
treatment of patients with premature ejaculation (PE). The current study has been designed as
a randomized single-blind placebo-controlled clinical trial. It was done on 150 lifelong PE
patients with normal erection. They were randomized evenly categorized into two treatment
groups. Group 1 (n₌75); was given on demand lidocaine 5% spray for 8 weeks. Group 2 (n₌75);
was given placebo in form on demand alcohol spray for 8 weeks.